Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Jan;35(1):90–93. doi: 10.1136/gut.35.1.90

Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT.

H Nyhlin 1, M V Merrick 1, M A Eastwood 1
PMCID: PMC1374639  PMID: 8307458

Abstract

Patients with Crohn's disease who suffer from longstanding diarrhoea that does not respond to conventional treatment pose a common clinical problem. Bile acid malabsorption is a possible cause, although its prevalence and clinical importance is unclear. This paper explores the clinical indications for referring patients with Crohn's disease for bile acid assessment and the extent of bile acid malabsorption in this selected group of patients. The selenium labelled bile acid SeHCAT was used to assess the effect of disease on the integrity of the enterohepatic circulation. Altogether 76% of the patients referred for bile acid assessment had longstanding diarrhoea that had not responded to conventional anti-diarrhoeal treatment or an increase in steroid therapy as their sole or predominant symptom. Ninety per cent of patients with bowel resections, almost exclusively ileocaecal, had abnormal SeHCAT retention (< 5% at seven days). Twenty eight per cent of patients with Crohn's disease who had not undergone resection 28% had a SeHCAT retention < 5%, signifying bile acid malabsorption. Nineteen of 22 patients given cholestyramine treatment subsequent to the SeHCAT test had a good symptomatic response. In conclusion, the prevalence of bile acid malabsorption in this selected group with Crohn's disease is sufficiently high to justify performing the SeHCAT test in order to separate the various differential diagnoses.

Full text

PDF
90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fagan E. A., Chadwick V. S., Baird I. M. SeHCAT absorption: a simple test of ileal dysfunction. Digestion. 1983;26(3):159–165. doi: 10.1159/000198883. [DOI] [PubMed] [Google Scholar]
  2. Farivar S., Fromm H., Schindler D., McJunkin B., Schmidt F. W. Tests of bile-acid and vitamin B12 metabolism in ileal Crohn's disease. Am J Clin Pathol. 1980 Jan;73(1):69–74. doi: 10.1093/ajcp/73.1.69. [DOI] [PubMed] [Google Scholar]
  3. Ferraris R., Jazrawi R., Bridges C., Northfield T. C. Use of a gamma-labeled bile acid (75SeHCAT) as a test of ileal function. Methods of improving accuracy. Gastroenterology. 1986 May;90(5 Pt 1):1129–1136. doi: 10.1016/0016-5085(86)90377-x. [DOI] [PubMed] [Google Scholar]
  4. Merrick M. V., Eastwood M. A., Anderson J. R., Ross H. M. Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT). J Nucl Med. 1982 Feb;23(2):126–130. [PubMed] [Google Scholar]
  5. Merrick M. V., Eastwood M. A., Ford M. J. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J (Clin Res Ed) 1985 Mar 2;290(6469):665–668. doi: 10.1136/bmj.290.6469.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Monks R., Boyd G. S. Biologic stability of tauro-23-[75Se] selena-25-homocholic acid. J Nucl Med. 1988 Aug;29(8):1411–1418. [PubMed] [Google Scholar]
  7. Nyhlin H., Brydon G., Danielsson A., Westman S. Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function. Hepatogastroenterology. 1984 Aug;31(4):187–191. [PubMed] [Google Scholar]
  8. Nyhlin H., Merrick M. V., Eastwood M. A., Brydon W. G. Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment. Gastroenterology. 1983 Jan;84(1):63–68. [PubMed] [Google Scholar]
  9. Orholm M., Pedersen J. O., Arnfred T., Rødbro P., Thaysen E. H. Evaluation of the applicability of the SeHCAT test in the investigation of patients with diarrhoea. Scand J Gastroenterol. 1988 Jan;23(1):113–117. doi: 10.3109/00365528809093859. [DOI] [PubMed] [Google Scholar]
  10. Otte J. J., Andersen J. R. The clinical value of faecal bile acid determination in patients with chronic diarrhoea of unknown origin. Scand J Gastroenterol. 1986 Jun;21(5):585–588. doi: 10.3109/00365528609003104. [DOI] [PubMed] [Google Scholar]
  11. Scarpello J. H., Sladen G. E. 14C-Glycocholate test in Crohn's disease--its value in assessment and treatment. Gut. 1977 Sep;18(9):736–741. doi: 10.1136/gut.18.9.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Williams A. J., Merrick M. V., Eastwood M. A. Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment. Gut. 1991 Sep;32(9):1004–1006. doi: 10.1136/gut.32.9.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. van Blankenstein M., Hoyset T., Hörchner P., Frenkel M., Wilson J. H. Faecal bile acid radioactivity, a sensitive and relatively simple test for ileal dysfunction. Neth J Med. 1977;20(6):248–252. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES